Clinical trial
Prediction of Placental Fetal Growth Restriction in High Risk Population (PoPFGR)
NCT06096805 is registered in ClinicalTrials.gov with Shanghai First Maternity and Infant Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prediction of Placental Fetal Growth Restriction in High Risk Population (PoPFGR)
- Lead sponsor
- Shanghai First Maternity and Infant Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 10, 2023
- Completion date
- December 30, 2025
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.